Oncology & Cancer

Targeting GITR in cancer immunotherapy

A new research perspective titled "Targeting GITR in cancer immunotherapy—there is no perfect knowledge" has been published in Oncotarget.

Oncology & Cancer

Study hints at how cancer immunotherapy can be safer

Cancer immunotherapy has revolutionized treatment of many forms of cancer by unleashing the immune system response against tumors. Immunotherapies that block checkpoint receptors like PD-1, proteins that limit the capacity ...

page 8 from 40